KAREN S MALUF MD NPI 1689658601

NPI Details

Karen S Maluf, MD is an internal medicine in Chickasha, OK. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. Karen S Maluf, MD NPI is 1689658601. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

2222 W IOWA AVE
CHICKASHA, OK
ZIP 73018-738
Phone: (405) 224-8111
Fax: (405) 222-9561

The NPI 1689658601 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Hemoglobin a1c level (HCPCS:83036)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Uric acid level, blood (HCPCS:84550)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0483)
• Testing for presence of drug, by chemistry analyzers (HCPCS:80307)
• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Hdl cholesterol level (HCPCS:83718)
• Urine microalbumin (protein) level (HCPCS:82043)
• Ldl cholesterol level (HCPCS:83721)
• Annual alcohol misuse screening, 15 minutes (HCPCS:G0442)
• Annual depression screening, 15 minutes (HCPCS:G0444)
• Advance care planning, first 30 minutes (HCPCS:99497)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
• Blood test, clotting time (HCPCS:85610)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0004)
• Liver enzyme (sgpt), level (HCPCS:84460)
• Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
• Triglycerides level (HCPCS:84478)
• Iron level (HCPCS:83540)
• Administration and interpretation of patient-focused health risk assessment (HCPCS:96160)
• Bacterial urine culture (HCPCS:87088)
• Vitamin d-3 level (HCPCS:82306)
• Ferritin (blood protein) level (HCPCS:82728)
• X-ray of chest, 2 views (HCPCS:71046)
• Thyroid hormone, t3 measurement, free (HCPCS:84481)
• Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a (HCPCS:G0179)
• Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique (HCPCS:87641)
• Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)
• Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
• Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique (HCPCS:87491)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique (HCPCS:87591)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Iron binding capacity (HCPCS:83550)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Testosterone (hormone) level, free (HCPCS:84402)
• Cholesterol level (HCPCS:82465)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days (HCPCS:99454)
• Management using the results of remote vital sign monitoring per calendar month, first 20 minutes (HCPCS:99457)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Magnesium level (HCPCS:83735)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment (HCPCS:99453)

The enumeration date for this NPI number is 12/2/2005 and was last updated on 6/28/2016.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.